Jose Ignacio
Rodríguez Barbosa
Instituto de Biomedicina de Sevilla
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biomedicina de Sevilla (4)
2020
-
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model
Cancer Immunology, Immunotherapy, Vol. 69, Núm. 6, pp. 1001-1014
2018
2017
-
Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier
Translational Research, Vol. 181, pp. 83-95.e3
2016
-
Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells
mAbs, Vol. 8, Núm. 3, pp. 478-490